Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders - Levy-Clarke, G; Jabs, D A; Read, R W; Rosenbaum, J T; Vitale, A; Van Gelder, R N (Ophthalmology, 2014)